Form 4 for ELV Elevance Health
Accepted 2021-11-03 00:00:00 ET · period of report 2021-11-01 · accession 0001156039-21-000097 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-11-03 | 2021-11-01 | ELV | Haytaian Peter D | EVP, Pres, DBG, IngenioRx | A - Grant | $0.00 | +1,167 | 22.7K | +5% | $0 |
| D | 2021-11-03 | 2021-11-01 | ELV | Haytaian Peter D | EVP, Pres, DBG, IngenioRx | A - Grant | $0.00 | +4,786 | 4,786 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-01 | A | A | 1,167 | $0.00 | 22,711 | D | — | — | (F1) Represents restricted share units. Restrictions lapse as follows: 389 shares each on 11/1/2022, 11/1/2023 and 11/1/2024. |
| 2 | Derivative | Employee Stock Option (Right to Buy) | 2021-11-01 | A | A | 4,786 | $0.00 | 4,786 | D | $428.76 · — to 2031-11-01 | 4,786 Common Stock | (F2) The option represents a right to purchase a total of 4,786 shares, and is exercisable in three annual installments, with two installments of 1,595 shares each and one installment of 1,596 shares, beginning on 11/01/2022, which is the one-year anniversary of the option grant date. |